Restore Libido, Energy and Confidence
AndroFeme® is a testosterone therapy developed specifically for women and may be considered where clinically appropriate for symptoms associated with low testosterone levels, most commonly after menopause.
Testosterone plays a role in female physiology, and reduced levels may be associated with changes in wellbeing.
Unlike our bespoke compounded testosterone cream, which can be prepared in different strengths according to your requirements, AndroFeme® is only available in one fixed strength. This may make it a suitable option for some women, while others may require a more personalised compounded preparation.
When may AndroFeme® be considered?
AndroFeme® may be considered for women who are experiencing symptoms such as:
- Reduced sexual desire
- Reduced arousal
- Low energy
- Reduced mental clarity
- Changes in wellbeing after menopause
- Ongoing symptoms despite wider hormone support
These symptoms can have many causes, so treatment is only considered after assessment and blood testing.
Treatment details
AndroFeme® is usually applied topically, commonly to the upper thigh or buttock area, as directed by the clinician. Your prescriber will confirm the correct dose and application instructions.
- Topical application
- Usually applied to the upper thigh or buttock
- Typical dose around 5 mg daily
- Tube lasting approximately 3 months
- Blood testing required before treatment
- Monitoring required after starting treatment
Suitable For Women who:
- are post-menopausal
- experience low libido
- have symptoms affecting wellbeing
- may already be on HRT
For women, Remivida Select offers both AndroFeme® and bespoke compounded testosterone cream options, allowing the clinician to choose either a fixed-strength female testosterone cream or a made-to-order preparation tailored to your blood results and clinical requirements.
Pricing
From £199 per 3-month treatment
Safety & Monitoring
Treatment is provided within a clinically supervised framework, including:
- Blood test required before treatment
- Monitoring required at 3–6 months
- Dose adjusted based on results
Important Information
AndroFeme® is a prescription-only medicine.
This product is not licensed in the UK and may be prescribed as an unlicensed medicine where clinically appropriate.
- Not suitable for everyone
- Requires assessment by a qualified clinician
- May cause side effects
- Prescribed only when the potential benefits are considered to outweigh the risks